Genomic Identification of Low-Density Granulocytes and Analysis of Their Role in the Pathogenesis of Systemic Lupus Erythematosus
- PMID: 31019061
- DOI: 10.4049/jimmunol.1801512
Genomic Identification of Low-Density Granulocytes and Analysis of Their Role in the Pathogenesis of Systemic Lupus Erythematosus
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the presence of low-density granulocytes (LDGs) with a heightened capacity for spontaneous NETosis, but the contribution of LDGs to SLE pathogenesis remains unclear. To characterize LDGs in human SLE, gene expression profiles derived from isolated LDGs were characterized by weighted gene coexpression network analysis, and a 92-gene module was identified. The LDG gene signature was enriched in genes related to neutrophil degranulation and cell cycle regulation. This signature was assessed in gene expression datasets from two large-scale SLE clinical trials to study associations between LDG enrichment, SLE manifestations, and treatment regimens. LDG enrichment in the blood was associated with corticosteroid treatment as well as anti-dsDNA, low serum complement, renal manifestations, and vasculitis, but the latter two of these associations were dependent on concomitant corticosteroid treatment. In addition, LDG enrichment was associated with enrichment of gene signatures induced by type I IFN and TNF irrespective of corticosteroid treatment. Notably, LDG enrichment was not found in numerous tissues affected by SLE. Comparison with relevant reference datasets indicated that LDG enrichment is likely reflective of increased granulopoiesis in the bone marrow and not peripheral neutrophil activation. The results have uncovered important determinants of the appearance of LDGs in SLE and have emphasized the likely role of LDGs in specific aspects of lupus pathogenesis.
Copyright © 2019 by The American Association of Immunologists, Inc.
Similar articles
-
Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus.Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25222-25228. doi: 10.1073/pnas.1908576116. Epub 2019 Nov 21. Proc Natl Acad Sci U S A. 2019. PMID: 31754025 Free PMC article.
-
Extracellular traps in peripheral blood mononuclear cell fraction in childhood-onset systemic lupus erythematosus.Sci Rep. 2024 Oct 5;14(1):23177. doi: 10.1038/s41598-024-74705-w. Sci Rep. 2024. PMID: 39369134 Free PMC article.
-
Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus.Ann Rheum Dis. 2019 Jul;78(7):957-966. doi: 10.1136/annrheumdis-2018-214620. Epub 2019 Apr 30. Ann Rheum Dis. 2019. PMID: 31040119 Free PMC article.
-
Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O.Front Immunol. 2021 Mar 4;12:649693. doi: 10.3389/fimmu.2021.649693. eCollection 2021. Front Immunol. 2021. PMID: 33746988 Free PMC article. Review.
-
Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity.Semin Immunopathol. 2013 Jul;35(4):455-63. doi: 10.1007/s00281-013-0375-7. Epub 2013 Apr 4. Semin Immunopathol. 2013. PMID: 23553215 Free PMC article. Review.
Cited by
-
Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus.JCI Insight. 2020 Aug 6;5(15):e140380. doi: 10.1172/jci.insight.140380. JCI Insight. 2020. PMID: 32759501 Free PMC article.
-
Low-density granulocytes in systemic autoimmunity and autoinflammation.Immunol Rev. 2023 Mar;314(1):313-325. doi: 10.1111/imr.13161. Epub 2022 Oct 28. Immunol Rev. 2023. PMID: 36305174 Free PMC article. Review.
-
Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosis.PLoS One. 2022 Dec 1;17(12):e0278295. doi: 10.1371/journal.pone.0278295. eCollection 2022. PLoS One. 2022. PMID: 36454773 Free PMC article.
-
Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.Front Immunol. 2019 Nov 29;10:2725. doi: 10.3389/fimmu.2019.02725. eCollection 2019. Front Immunol. 2019. PMID: 31849944 Free PMC article.
-
Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway.Cell Biol Toxicol. 2023 Dec;39(6):3287-3304. doi: 10.1007/s10565-023-09833-6. Epub 2023 Oct 7. Cell Biol Toxicol. 2023. PMID: 37804401
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical